C
Citius Oncology, Inc. (CTOR)
NCM – Real vaqt narxi. Valyuta: USD
0.62
-0.04 (-6.06%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
0.64
+0.02 (3.71%)
Bozordan keyin: Jun 26, 2026, 5:34 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
0.62
-0.04 (-6.06%)
Yopilishda: Jun 26, 2026, 4:00 PM EDT
0.64
+0.02 (3.71%)
Bozordan keyin: Jun 26, 2026, 5:34 PM EDT
Citius Oncology, Inc. innovatsion maqsadli onkologiya terapiyalarini ishlab chiqish va tijoratlashtirishga qaratilgan. Kompaniya, shuningdek, nodir kasallik - qaytalangan yoki refrakter teri T-hujayrali limfomasi, noto'g'ri limfomaning kam uchraydigan shakli - kattalar bemorlarini davolash uchun LYMPHIRni ishlab chiqish bilan shug'ullanadi. Kompaniya shtab-kvartirasi Cranford, Nyu-Jersi shahrida joylashgan. Citius Oncology, Inc. Leonard-Meron Biosciences, Inc.ning sho'ba korxonasidir.
| Ism | Lavozim |
|---|---|
| Dr. Myron S. Czuczman M.D. | Executive VP & Chief Medical Officer |
| Mr. Jaime Bartushak | Chief Financial Officer & Treasurer |
| Mr. Leonard L. Mazur | CEO, President & Executive Chairman |
| Mr. Myron Z. Holubiak | Secretary & Executive Vice Chairman |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-06-01 | 8-K | ea0292903-8k_citius.htm |
| 2026-05-29 | S-3 | ea0291447-s3_citius.htm |
| 2026-05-29 | DEF 14C | ea0292248-def14c_citius.htm |
| 2026-05-19 | PRE 14C | ea0290807-pre14c_citius.htm |
| 2026-05-15 | 8-K | ea0291035-8k_citius.htm |
| 2026-05-15 | 10-Q | ea0290553-10q_citius.htm |
| 2026-05-06 | 8-K | ea0289297-8k_citius.htm |
| 2026-04-29 | 8-K | ea0288202-8k_citius.htm |
| 2026-04-28 | 8-K | ea0288020-8k_citius.htm |
| 2026-03-31 | 8-K | ea0284321-8k_citius.htm |